Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

sections

Your RPS

RPS defends against corrections made to new BNF

The Royal Pharmaceutical Society (RPS) has issued a statement defending the regular updates made to the new BNF to add new information and make corrections. In the image, a set of newly designed BNFs

Source: PharmPress / RPS

The Royal Pharmaceutical Society says that the number of “clinically important” errors in the new BNF remains low

The Royal Pharmaceutical Society (RPS) has issued a statement defending the regular updates made to the new BNF to add new information and make corrections.

The Society says the number of corrections required in the new BNF has not increased markedly, but that the number of channels used to communicate corrections has increased. It also highlights that although recent reports to the BNF team have been described as “errors” they are in fact changes to the way content is represented and that the number of “clinically important” errors in the updated text remains low.

Neal Patel, pictured, head of corporate communications at the RPS, explained the reason behind the statement: “We issued the statement to ensure people had the correct information about the new BNF.

Source: Royal Pharmaceutical Society

Neal Patel, head of corporate communications at the RPS, says the Society issued the statement to ensure people had the correct information about the new BNF

Neal Patel, head of corporate communications at the RPS, explains the reason behind the statement: “We issued the statement to ensure people had the correct information about the new BNF. The print edition has a new layout which people are getting used to. As always, we are happy to hear feedback or if pharmacists would like advice they can contact the RPS support service.”

The RPS emphasises that the BNF was restructured to better facilitate digital production for the future, improve user experience and to bring information into one place in print. However, in order to have access to information about any changes made, the RPS recommends that print users sign up to the monthly newsletter and regularly cross check with the updated electronic versions, particularly for medicines less familiar to them.

The RPS encourages all users of the BNF to continue to send feedback directly to the BNF team at editor@bnf.org to aid the ongoing development of the publication.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20200174

Readers' comments (2)

  • Helen Garrood

    I like the new look BNF especially as all the information about a drug is to be found in one place and you don't have to search a dozen different page references to find Drug monitoring requirements for example.
    It feels more clinical and more authoritarian. Each drug is broken down into indication sections and it answers all the little fiddly questions we are always asking.

    Unsuitable or offensive? Report this comment

  • Lynn Haygarth

    The introduction of the new BNF is not without its complications. Part of my role is to introduce the BNF during the non- medical prescribing training course. Although I have completed the CPPE training course I am still finding it difficult to answer all the questions raised.
    In my opinion, more training is required.
    Lynn Haygarth 68743

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 1 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 2 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Foundation in Pharmacy Practice

    Foundation in Pharmacy Practice

    A practical and succinct overview of the principal pharmacy practice topics, for new pharmacy students.

    £33.00Buy now
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • The Royal Pharmaceutical Society (RPS) has issued a statement defending the regular updates made to the new BNF to add new information and make corrections. In the image, a set of newly designed BNFs
  • Neal Patel, pictured, head of corporate communications at the RPS, explained the reason behind the statement: “We issued the statement to ensure people had the correct information about the new BNF."

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.